98 related articles for article (PubMed ID: 28559221)
1. Amoxycillin and Metronidazole Therapy for Helicobacter pylori Eradication: A 10-Year Trend in Turin, Italy.
Ribaldone DG; Astegiano M; Saracco G; Pellicano R
Balkan Med J; 2017 May; 34(3):290-291. PubMed ID: 28559221
[No Abstract] [Full Text] [Related]
2. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
3. Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Tursi A; Cammarota G; Papa A; Montalto M; Fedeli G; Gasbarrini G
Am J Gastroenterol; 1996 Aug; 91(8):1668-70. PubMed ID: 8759696
[No Abstract] [Full Text] [Related]
4. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
5. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study.
Adriani A; Astegiano M; Smedile A; Rizzetto M; Pellicano R
Minerva Med; 2013 Aug; 104(4):495-6. PubMed ID: 24008612
[No Abstract] [Full Text] [Related]
8. Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients.
Tucci A; Varoli O; Corinaldesi R; Stanghellini V; Gasperoni S; Paparo GF; Ricci-Maccarini M; La Placa M; Barbara L
Ital J Gastroenterol; 1993; 25(2):65-7. PubMed ID: 8513165
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori: what eradication regimen in a tropical area after the failure of two separate lines of eradication including metronidazole and clarithromycin?].
Razafimahefa SH; Rakotoarivelo RA; Andriamampionona TF; Rabenjanahary TH; Ramanampamonjy RM
Med Sante Trop; 2013; 23(1):108-9. PubMed ID: 23360589
[TBL] [Abstract][Full Text] [Related]
10. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
11. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
Hu TH; Chuah SK; Hsu PI; Wu DC; Tai WC; Chiu YC; Wu KL; Kuo CM; Hu ML
Am J Med Sci; 2011 Sep; 342(3):177-81. PubMed ID: 21804375
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
Kudo T; Fujinami H; Ando T; Nishikawa J; Ogawa K; Hosokawa A; Orihara T; Murakami J; Takahara T; Sugiyama T
Helicobacter; 2012 Aug; 17(4):277-81. PubMed ID: 22759327
[TBL] [Abstract][Full Text] [Related]
16. [Triple treatment for the eradication of Helicobacter pylori infection].
Calvet X; Campo R; Brullet E; Rué M
Med Clin (Barc); 1998 Dec; 111(19):759. PubMed ID: 9922963
[No Abstract] [Full Text] [Related]
17. [Eradication of Helicobacter pylori].
Herszényi L
Orv Hetil; 2003 Oct; 144(40):1991-2. PubMed ID: 14626641
[No Abstract] [Full Text] [Related]
18. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
19. [The choice of treatment in HP associated ulcer: metronidazole or amoxicillin--nothing else!].
Schmidt D
Lakartidningen; 2011 May 4-10; 108(18):997. PubMed ID: 21809531
[No Abstract] [Full Text] [Related]
20. Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
Adachi T; Matsui S; Watanabe T; Okamoto K; Okamoto A; Kono M; Yamada M; Nagai T; Komeda Y; Minaga K; Kamata K; Yamao K; Takenaka M; Asakuma Y; Sakurai T; Nishida N; Kashida H; Kudo M
Oncology; 2017; 93 Suppl 1():15-19. PubMed ID: 29258111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
